Abstract
BackgroundPatients with rheumatoid arthritis (RA) are at increased cardiovascular risk with contribution of both inflammation and traditional risk factors. Dyslipidemia is an important risk factor and lipid-lowering therapy plays a...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have